These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 11753547)
1. The kinetics of circulating cytokines including IL-6, TNF-alpha, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation. Min CK; Lee WY; Min DJ; Lee DG; Kim YJ; Park YH; Kim HJ; Lee S; Kim DW; Lee JW; Min WS; Kim CC Bone Marrow Transplant; 2001 Nov; 28(10):935-40. PubMed ID: 11753547 [TBL] [Abstract][Full Text] [Related]
2. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation. Ferrà C; de Sanjosé S; Gallardo D; Berlanga JJ; Rueda F; Marìn D; de la Banda E; Ancìn I; Peris J; Garcìa J; Grañena A Haematologica; 1998 Dec; 83(12):1082-7. PubMed ID: 9949625 [TBL] [Abstract][Full Text] [Related]
3. Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease. Imoto S; Oomoto Y; Murata K; Das H; Murayama T; Kajimoto K; Sugimoto T; Gomyo H; Nakagawa T; Nishimura R; Koizumi T Int J Hematol; 2000 Jul; 72(1):92-7. PubMed ID: 10979216 [TBL] [Abstract][Full Text] [Related]
4. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients. Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290 [TBL] [Abstract][Full Text] [Related]
5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
6. Diarrhea during the conditioning regimen is correlated with the occurrence of severe acute graft-versus-host disease through systemic release of inflammatory cytokines. Liu D; Yan C; Xu L; Wang Y; Han W; Zhang X; Liu K; Huang X Biol Blood Marrow Transplant; 2010 Nov; 16(11):1567-75. PubMed ID: 20546909 [TBL] [Abstract][Full Text] [Related]
7. Serial measurements of interleukin-6, interleukin-8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients. George JF; Kirklin JK; Naftel DC; Bourge RC; White-Williams C; McGiffin DC; Savunen T; Everson MP J Heart Lung Transplant; 1997 Oct; 16(10):1046-53. PubMed ID: 9361247 [TBL] [Abstract][Full Text] [Related]
8. Cytokine production during myeloablative and reduced intensity therapy before allogeneic stem cell transplantation. Remberger M; Sundberg B Haematologica; 2004 Jun; 89(6):710-6. PubMed ID: 15194539 [TBL] [Abstract][Full Text] [Related]
12. Plasma levels of tumor necrotic factor-alpha and interleukin-6, -8 during orthotopic liver transplantation and their relations to postoperative pulmonary complications. Wen XH; Kong HY; Zhu SM; Xu JH; Huang SQ; Chen QL Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):38-41. PubMed ID: 14969835 [TBL] [Abstract][Full Text] [Related]
13. Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Reddy V; Winer AG; Eksioglu E; Meier-Kriesche HU; Schold JD; Wingard JR Biol Blood Marrow Transplant; 2005 Dec; 11(12):1014-21. PubMed ID: 16338624 [TBL] [Abstract][Full Text] [Related]
14. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. Gogos CA; Drosou E; Bassaris HP; Skoutelis A J Infect Dis; 2000 Jan; 181(1):176-80. PubMed ID: 10608764 [TBL] [Abstract][Full Text] [Related]
15. Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantation. Fowler DH; Odom J; Steinberg SM; Chow CK; Foley J; Kogan Y; Hou J; Gea-Banacloche J; Sportes C; Pavletic S; Leitman S; Read EJ; Carter C; Kolstad A; Fox R; Beatty GL; Vonderheide RH; Levine BL; June CH; Gress RE; Bishop MR Biol Blood Marrow Transplant; 2006 Nov; 12(11):1150-60. PubMed ID: 17085308 [TBL] [Abstract][Full Text] [Related]
16. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Schots R; Kaufman L; Van Riet I; Ben Othman T; De Waele M; Van Camp B; Demanet C Leukemia; 2003 Jun; 17(6):1150-6. PubMed ID: 12764383 [TBL] [Abstract][Full Text] [Related]
17. [Changes of IL-2, IL-8, IL-10 and TNF-alpha levels in sera of patients with acute graft-versus-host disease]. Wang SH; Da WM; Jin HJ; Jing Y; Yan GT Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):755-8. PubMed ID: 16928315 [TBL] [Abstract][Full Text] [Related]
18. Monitoring cytokine production in peripheral blood during acute graft-versus-host disease following allogeneic bone marrow transplantation. Rowbottom AW; Riches PG; Downie C; Hobbs JR Bone Marrow Transplant; 1993 Dec; 12(6):635-41. PubMed ID: 8136747 [TBL] [Abstract][Full Text] [Related]
19. Early elevation of C-reactive protein correlates with severe infection and nonrelapse mortality in children undergoing allogeneic stem cell transplantation. McNeer JL; Kletzel M; Rademaker A; Alford K; O'Day K; Schaefer C; Duerst R; Jacobsohn DA Biol Blood Marrow Transplant; 2010 Mar; 16(3):350-7. PubMed ID: 20005964 [TBL] [Abstract][Full Text] [Related]
20. Serum cholinesterase is an early and sensitive marker of graft-versus host-disease (GVHD) and transplant-related mortality (TRM). Bacigalupo A; Oneto R; Bruno B; Lamparelli T; Gualandi F; Bregante S; Raiola AM; Di Grazia C; Dominietto A; Lombardi A; Frassoni F; Van Lint MT Bone Marrow Transplant; 2001 Dec; 28(11):1041-5. PubMed ID: 11781614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]